Cargando…
Searching for Novel Candidate Small Molecules for Ameliorating Idiopathic Pulmonary Fibrosis: a Narrative Review
Idiopathic pulmonary fibrosis (IPF) can be defined as a progressive chronic pulmonary disease showing scarring in the lung parenchyma, thereby resulting in increase in mortality and decrease in the quality of life. The pathophysiologic mechanism of fibrosis in IPF is still unclear. Repetitive microi...
Autores principales: | Kim, Kyung-il, Hossain, Rajib, Li, Xin, Lee, Hyun Jae, Lee, Choong Jae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468426/ https://www.ncbi.nlm.nih.gov/pubmed/37254717 http://dx.doi.org/10.4062/biomolther.2023.056 |
Ejemplares similares
-
Small Molecule Drug Candidates for Managing the Clinical Symptoms of COVID-19: a Narrative Review
por: Yun, Chawon, et al.
Publicado: (2021) -
Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosis
por: Han, SongYi, et al.
Publicado: (2019) -
Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation
por: Moon, Sung Woo, et al.
Publicado: (2019) -
Meclofenamate Suppresses MUC5AC Mucin Gene Expression by Regulating the NF-kB Signaling Pathway in Human Pulmonary Mucoepidermoid NCI-H292 Cells
por: Ryu, Jiho, et al.
Publicado: (2023) -
Impact of mediastinal lymph node enlargement on the prognosis of idiopathic pulmonary fibrosis
por: Sin, Sooim, et al.
Publicado: (2018)